WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 26'2001 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 53'7801 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 28'829  28'288  27'762  27'258  26'796  20'145  16'206  9'843 
Births 561  565  567  569  570  563  577  435 
Surviving infants 555  558  561  562  563  551  557  406 
Pop. less than 5 years 2'924  2'954  2'983  3'019  2'983  2'801  2'715  1'819 
Pop. less than 15 years 8'369  8'350  8'352  8'375  8'328  7'742  6'888  4'369 
Female 15-49 years 6'776  6'731  6'649  6'532  6'446  4'668  3'179  1'934 

Number of reported case

(Click for retrospective incidence data for Saudi Arabia)
Diphtheria 99 
Japanese encephalitis
Measles 1'164  294  362  334  82  5'439  46'115 
Mumps 1'172  64  26  610  138 
Pertussis 13  112  9'815 
Polio* 257 
Rubella 1'164  18  35  12 
Rubella (CRS)
Tetanus (neonatal) 10  14  14  10  13 
Tetanus (total) 27  21  26  10  15  33  124 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saudi Arabia)
Vaccine year result method % card seen                                                
BCG 1995  98  FHS   83  99  99  98  98  98  94  90  33 
DTP1 1995  98  FHS   83  98  98  99  98  98  95 
DTP3 1995  93  FHS   83  98  98  98  98  98  95  92  41 
HepB_BD          99  99  98  98  98 
HepB3 1995  92  FHS   83  98  98  98  98  98  93  66 
Hib3          98  98  98  98  98  96 
JapEnc         
MCV 1995  97  FHS   83  98  98  98  98  98  94  88 
MCV2          99  98  97  98 
PCV1          98  98  99  98 
PCV3          98  98  98  98  98 
Pol3 1995  93  FHS   83  98  98  98  98  98  95  92  41 
Rota1          96 
Rota_last          84 
Rubella1          98  98  98  98  98 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saudi Arabia)
BCG 99  99  98  98  98  94  90  33 
DTP1 98  98  99  98  98  95  97  66 
DTP3 98  98  98  98  98  95  92  41 
HepB3 98  98  98  98  98  93  66 
HepB_BD 99  99  98  98  98 
Hib3 98  98  98  98  98 
MCV 98  98  98  98  98  94  88 
MCV2 99  98  97  98  98 
PCV3 98  98  98  98  98 
Pol3 98  98  98  98  98  95  92  41 
Rota_last 84 

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT < 7 years; Yes DTP contrindicated
DTaP 6 years; Yes
DTaPHib 18 months; Yes
DTaPHibHepIPV 2, 4, 6 months; Yes
HepA 18, 24 months;
HepB Birth; Yes
Influenza > 6 months; Yes
MMR 12, 18 months; 6 years; Yes
Measles 9 months; Yes
MenACWY > 2 years; Yes Pilgrims and routinely from January 2013 (conjugate vaccine)
OPV 6, 12, 18 months; 6 years; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Pneumo_ps Yes high risk groups
Rotavirus 2, 4 months; Yes
Td >= 7 years; Yes
Typhoid Yes food handlers
Varicella 12 months; 6 years;
YF travellers to infected countries

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 5Y       
Nº of districts with microplans that include activities to raise immunization coverage number 20  20    NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 20  20  20  20  20  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 20  18  20  19  17  16   
% of districts with MCV1 coverage >=95% From 0 to 100% 100  90  100  95  85  80   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   100      100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.